The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Spanish Melanoma Multidisciplinary Group (GEM): Long-term survivors treated with ipilimumab (IPI) in the expanded access programme (EAP).
Cristina Hernando
No relevant relationships to disclose
Virtudes Soriano
No relevant relationships to disclose
Jose Pablo Berros
No relevant relationships to disclose
Ana Maria Arance
No relevant relationships to disclose
Karmele Mujika
No relevant relationships to disclose
Delvys Rodriguez Abreu
No relevant relationships to disclose
Lorenzo Alonso
Honoraria - Bristol-Myers Squibb
Martina Alonso
No relevant relationships to disclose
Lorena Yapur
Employment or Leadership Position - Bristol-Myers Squibb
Alfonso Berrocal
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Expert Testimony - Bristol-Myers Squibb